Verrica Pharmaceuticals Inc.
09/27/2024 | Press release | Distributed by Public on 09/27/2024 14:16
Management Change/Compensation Form 8 K
| Item 5.02 |
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
On September 23, 2024, Terence Kohler, Chief Financial Officer of the Company, notified the Company of his resignation from his position, effective October 4, 2024 (the "Separation Date"), to pursue a new business opportunity.